Article Details
Retrieved on: 2024-09-24 19:11:10
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article details Merck Animal Health's launch of a new feline leukemia virus (FeLV) vaccine within its NOBIVAC NXT platform. This professional service aims to protect cats from FeLV, a common and severe disease, utilizing RNA-particle technology.
Article found on: www.dvm360.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here